Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia

Brain

Volumn 120, Issue 10, 1997, Pages 1723-1737

  Andersen, P M ^a   Nilsson, P ^a   Keranen M L ^d   Forsgren, L ^a   Hagglund J ^b   Karlsborg, M ^e   Ronnevi, L O ^c   Gredal, O ^f   Marklund, S L ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Malar Hospital   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LAPLAND CENTRAL HOSPITAL   (Finland)

^e HVIDOVRE HOSPITAL   (Denmark)

^f GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Amyotrophic lateral sclerosis; Asp76Tyr CuZn SOD mutation; Asp90Ala CuZn SOD mutation; Progressive bulbar palsy

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; FACIAL NERVE PARALYSIS; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; PHENOTYPE; PRIORITY JOURNAL; SCANDINAVIA;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BULBAR PALSY, PROGRESSIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MUTATION; PEDIGREE; PHENOTYPE; SCANDINAVIA; SUPEROXIDE DISMUTASE; VARIATION (GENETICS);

EID: 0030749160     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.10.1723     Document Type: Article

References (88)

1. Andersen PM, Nilsson P, Ala-Hurula V, Keränen M-L, Tarvainen I, Haltia T, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 1995; 10: 61-6.
2. Andersen PM, Forsgren L, Binzer M, Nilsson P, Ala-Hurula V, Keränen M-L, et al. Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119: 1153-72.
3. Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, et al. Mild ALS in Japan associated with novel SOD mutation [letter] [published erratum appears in Nat Genet 1994; 6: 225]. Nat Genet 1993; 5: 323-4.
4. Aoki M, Abe K, Houi K, Ogasawara M, Matsubara Y, Kobayashi T, et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn Superoxide dismutase mutation. Ann Neurol 1995; 37: 676-9.
5. Aran FA. Researches sur une maladie non encore décrite du système musculaire (atrophie musculaire progressive). Arch Gén Méd 1850; 24; 4-35, 172-214.
6. Averback P, Crocker P. Regular involvement of Clarke's nucleus in sporadic amyotrophic lateral sclerosis. Arch Neurol 1982; 39; 155-6.
7. Beckman G. Population studies in northern Sweden. VI. Polymorphism of Superoxide dismutase. Hereditas 1973; 73: 305-10.
8. Bell C. The nervous system of the human body. 2nd ed. London: Longman, Rees, Orme, Brown & Green, 1830.
9. Bereznai B, Winkler A, Borasio GD, Gasser T. A novel SOD1 mutation in an Austrian family with amyotrophic lateral sclerosis. Neuromuscul Disord 1997; 7: 113-6.
10. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu Z-S, Wong PC, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994; 91: 8292-6.
11. Bordo D, Djinovic K, Bolognesi M. Conserved patterns in the Cu,Zn superoxide dismutase family. J Mol Biol 1994; 238: 366-86.
12. Bowling AC, Barkowski EE, McKenna-Yasek D, Sapp P, Horvitz HR, Beal MF, et al. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem 1995; 64: 2366-9.
13. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci 1994; 124 Suppl: 96-107.
14. Calder VL, Domigan NM, George PM, Donaldson IM, Winterbourn CC. Superoxide dismutase (glu100-→gly) in a family with inherited motor neuron disease: detection of mutant superoxide dismutase activity and the presence of heterodimers. Neurosci Lett 1995; 189: 143-6.
15. Charcot JM. Lectures on the diseases of the nervous system, Vol. 2, Series 2. [Sigerson G, translator and editor]. London: New Sydenham Society, 1881: 195-7.
16. Charcot JM, Joffroy A. Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antéro-latéraux de la moelle épinière. Arch Physiol Norm Path 1869; 2: 744-60.
17. Deng H-X, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung W-Y, et al. Amyotrophic lateral sclerosis and structural defects in CuZn superoxide dismutase [see comments]. Science 1993; 261: 1047-51. Comment in: Science 1993; 261: 986.
18. Deng H-X, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung W-Y, et al. Amyotrophic lateral sclerosis and structural defects in CuZn superoxide dismutase [see comments]. Science 1993; 261: 1047-51. Comment in: Science 1993; 261: 986.
19. Deng H-X, Tainer JA, Mitsumoto H, Ohnishi A, He X, Hung W-Y, et al. Two novel SODI mutations in patients with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1113-6.
20. Duchenne GBA. Paralysie musculaire progressive de la langue, du voile du palais et des lèvres: affection non encore décrite comme espèce morbide distincte. Arch Gen Med 1860; 16: 283-96, 431-45.
21. Elshafey A, Lanyon WG, Connor JM. Identification of a new missense mutation in exon 4 of the Cu/Zn Superoxide dismutase (SOD-1) gene in a family with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 363-4.
22. Enayat ZE, Orrell RW, Claus A, Ludolph A, Bachus R, Brockmüller J, et al. Two novel mutations in the gene for copper zinc Superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Mol Genet 1995; 4: 1239-40.
23. Engel WK, Kurland LT, Klatzo I. An inherited disease similar to amyotrophic lateral sclerosis with a pattern of posterior column involvement. An intermediate form? Brain 1959; 82: 203-20.
24. Esteban J, Rosen DR, Bowling AC, Sapp P, McKenna-Yasek D, O'Regan JP, et al. Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn Superoxide dismutase in patients with amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 997-8.
25. Forsgren L, Almay BGL, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983; 68: 20-9.
26. Frecker MF, Fraser FC, Andermann E, Pryse-Phillips WEM. Association between Alzheimer disease and amyotrophic lateral sclerosis? [see comments]. Can J Neurol Sci 1990; 17: 12-4. Comment in: Can J Neurol Sci 1990; 17: 352.
27. Frecker MF, Fraser FC, Andermann E, Pryse-Phillips WEM. Association between Alzheimer disease and amyotrophic lateral sclerosis? [see comments]. Can J Neurol Sci 1990; 17: 12-4. Comment in: Can J Neurol Sci 1990; 17: 352.
28. Getzoff ED, Tainer JA, Stempien MM, Bell GI, Hallewell RA. Evolution of CuZn Superoxide dismutase and the Greek key β-barrel structural motif [published erratum appears in Proteins 1990; 8: 398-9]. Proteins 1989; 5: 322-36.
29. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985; 232: 295-300.
30. Gunnarsson L-G, Dahlbom K, Strandman E. Motor neuron disease and dementia reported among 13 members of a single family. Acta Neurol Scand 1991; 84: 429-33.
31. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human CuZn Superoxide dismutase mutation [see comments] [published erratum appears in Science 1995; 269: 149]. Science 1994; 264: 1772-5. Comment in: Science 1994; 264: 1663-4, Comment in: Science 1994; 266: 1586-7.
32. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human CuZn Superoxide dismutase mutation [see comments] [published erratum appears in Science 1995; 269: 149]. Science 1994; 264: 1772-5. Comment in: Science 1994; 264: 1663-4, Comment in: Science 1994; 266: 1586-7.
33. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human CuZn Superoxide dismutase mutation [see comments] [published erratum appears in Science 1995; 269: 149]. Science 1994; 264: 1772-5. Comment in: Science 1994; 264: 1663-4, Comment in: Science 1994; 266: 1586-7.
34. Hansen C, Gredal O, Werdelin L, Andersen PM, Marklund SL, Nilsson P, et al. A 4-bp insertion in the CuZn-superoxide dismutase gene associated with familial amyotrophic lateral sclerosis. Hum Mutat 1997. In press.
35. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Brain 1995; 118: 707-19.
36. Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol 1967; 16: 232-43.
37. Hirano M, Fujii J, Nagai Y, Sonobe K, Okamoto K, Araki H, et al. A new variant Cu/Zn Superoxide dismutase (Val7-→Glu) deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 204: 572-7.
38. Horton WA, Eldridge R, Brody JA. Familial motor neuron disease. Evidence for at least three different types. Neurology 1976; 26: 460-5.
39. Hosler BA, Nicholson GA, Sapp PC, Chin W, Orrell RW, de Belleroche JS, et al. Three novel mutations and two variants in the gene for Cu/Zn Superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromuscul Disord 1996; 6: 361-6.
40. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurologial disorders: a review. [Review]. Brain 1981; 104: 217-47.
41. Ikeda M, Abe K, Aoki M, Ogasawara M, Kameya T, Watanabe M, et al. A novel point mutation in the Cu/Zn Superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995a; 4: 491-2.
42. Ikeda M, Abe K, Aoki M, Sahara M, Watanabe M, Shoji M, et al. Variable clinical symptoms in familial amyotrophic lateral sclerosis with a novel point mutation in the Cu/Zn Superoxide dismutase gene. Neurology 1995b; 45: 2038-42.
43. Ince PG, Shaw PJ, Slade JY, Jones C, Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol (Berl) 1996; 92: 395-403.
44. Jackson M, Al-Chalabi A, Enayat ZE, Leigh PN, Morrison KE. Mutations in SOD-1 in sporadic ALS [abstract]. Am J Hum Genet 1996; 59 Suppl: A265.
45. Jones CT, Swingler RJ, Brock DJH. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet 1994a; 3: 649-50.
46. Jones CT, Shaw PJ, Chari G, Brock DJH. Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cell Probes 1994b; 8: 329-30.
47. Jones CT, Swingler RJ, Simpson SA, Brock DJH. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290-2.
48. Kaplan JP, Brooks BR, Mitsumoto H, Alston SR, Campbell W, Deng HX, et al. Atypical familial amyotrophic lateral sclerosis [abstract]. Am J Hum Genet 1996; 59 Suppl: A265.
49. Kawamata J, Shimohama S, Hasegawa H, Imura T, Kimura J, Ueda K. Deletion and point mutations in superoxide dismutase-1 gene in amyotrophic lateral sclerosis [abstract]. XIth TMIN International Symposium: Amyotrophic Lateral Sclerosis, Progress and Perspectives in basic research and clinical application, Tokyo, 1995: 14.
50. Kirjarinta M, Fellman J, Gustafsson C, Keisala E, Eriksson AW. Two rare electrophoretic variants of erythrocyte enzymes in Finland [abstract]. Scand J Clin Lab Invest 1969; 23 Suppl 108: 46.
51. Kolde G, Bachus R, Ludolph AC. Skin involvement in amyotrophic lateral sclerosis. Lancet 1996; 347: 1226-7.
52. Kostrzewa M, Burck-Lehmann, Müller U. Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn Superoxide dismutase-1 gene. Hum Mol Genet 1994; 3: 2261-2.
53. Kostrzewa M, Damian MS, Müller U. Superoxide dismutase 1: identification of a novel mutation in a case of familial amyotrophic lateral sclerosis. Hum Genet 1996; 98: 48-50.
54. Kristensen O, Melgaard B. Motor neuron disease. Prognosis and epidemiology. Acta Neurol Scand 1977; 56: 299-308.
55. Marklund S. Spectrophotometric study of spontaneous disproportionation of Superoxide anion radical and sensitive direct assay for Superoxide dismutase. J Biol Chem 1976; 251: 7504-7.
56. Marklund SL. Direct assay with potassium Superoxide. In: Greenwald RA editor. Handbook of methods for oxygen radical research. Boca Raton (FL): CRC Press, 1985: 249-55.
57. Morita M, Aoki M, Abe K, Hasegawa T, Sakuma R, Onodera Y, et al. A novel two-base mutation in the Cu/Zn Superoxide dismutase gene associated with familial amyotrophic lateral sclerosis in Japan. Neurosci Lett 1996; 205: 79-82.
58. Moulard B, Camu W, Brice A, Salachas F, Meininger V, Malafosse A. A previously undescribed mutation in the SOD1 gene in a French family with atypical ALS [abstract]. 6th International Symposium on ALS/MND, Pathogenesis and treatment of ALS/MND II, Dublin, Ireland, November 1995: 22.
59. Nakano R, Sato S, Inuzuka T, Sakimura K, Mishina M, Takahashi H, et al. A novel mutation in Cu/Zn Superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Bichem Biophys Res Commun 1994; 200: 695-703.
60. Nakashima K, Watanabe Y, Kuno N, Nanba E, Takahashi K. Abnormality of Cu/Zn Superoxide dismutase (SOD1) activity in Japanese familial amyotrophic lateral sclerosis with two base pair deletion in the SOD1 gene. Neurology 1995; 45: 1019-20.
61. Nevanlinna HR. The Finnish population structure. A genetic and genealogical study. Hereditas 1972; 71: 195-236.
62. Orrell R, de Belleroche J, Marklund S, Bowe F, Hallewell R. A novel SOD mutant and ALS [letter] [see comments]. Nature 1995a; 374: 504-5. Comment in: Nature 1995; 378: 342-3.
63. Orrell R, de Belleroche J, Marklund S, Bowe F, Hallewell R. A novel SOD mutant and ALS [letter] [see comments]. Nature 1995a; 374: 504-5. Comment in: Nature 1995; 378: 342-3.
64. Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJM, Belleroche JS. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry 1995b; 59: 266-70.
65. Orrell RW, Habgood JJ, Gardiner I, King AW, Bowe FA, Hallewell RA, et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc Superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997a; 48: 746-51.
66. Orrell RW, Habgood JJ, Shepherd DI, Donnai D, de Belleroche J. A novel mutation of SOD-1 (Gly108Va1) in familial amyotrphic lateral sclerosis. Eur J Neurol 1997b; 4: 48-51.
67. Pramatarova A, Goto J, Nanba E, Nakashima K, Takahashi K, Takagi A, et al. A two basepair deletion in the SOD1 gene causes familial amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 2061-2.
68. Pramatarova A, Figlewicz DA, Krizus A, Han FY, Ceballos-Picot I, Nicole A, et al. Identification of new mutations in the Cu/Zn Superoxide dismutase gene of patients with familial amyotrophic lateral sclerosis. Am J Hum Genet 1995; 56: 592-6.
69. Rabizadeh S, Gralla EB, Borchelt DR, Gwinn R, Valentine JS, Sisodia S, et al. Mutations associated with amyotrophic lateral sclerosis convert Superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 1995; 92: 3024-8.
70. Radunovic A, Leigh PN. Cu/Zn Superoxide dismutase gene mutations in amyotrophic lateral sclerosis. correlation between genotype and clinical features. [Review]. J Neurol Neurosurg Psychiatry 1996; 61: 565-72.
71. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine Superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995; 92: 689-93.
72. Robberecht W, Aguirre T, Van den Bosch L, Tilkin P, Cassiman JJ, Matthijs G. D90A heterozygosity in the SOD1 gene is associated with familial and apparently sporadic amyotrophic lateral sclerosis. Neurology 1996; 47: 1336-9.
73. Rosati G, Pinna L, Granieri E, Aiello I, Tola R, Agnetti V, et al. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand 1977; 55: 231-44.
74. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati, A et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis [published erratum appears in Nature 1993; 364: 362] [see comments]. Nature 1993; 362: 59-62. Comment in: Nature 1993; 362: 20-1.
75. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati, A et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis [published erratum appears in Nature 1993; 364: 362] [see comments]. Nature 1993; 362: 59-62. Comment in: Nature 1993; 362: 20-1.
76. Rosen DR, Bowling AC, Patterson D, Usdin TB, Sapp P, Mezey E, et al. A frequent ala 4 to val Superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3: 981-7.
77. Sapp PC, Rosen DR, Hosler BA, Esteban J, McKenna-Yasek D, O'Regan JP, et al. Identification of three novel mutations in the gene for Cu/Zn Superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscul Disord 1995; 5: 353-7.
78. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993; 16: 325-32.
79. Shibata N, Hirano A, Kobayashi M, Siddique T, Deng H-X, Hung W-Y, et al. Intense Superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996; 55: 481-90.
80. Siddique T, Nijhawan D, Hentati A. Molecular genetic basis of familial ALS. [Review]. Neurology 1996; 47 (4 Suppl 2): S27-35.
81. Suthers G, Laing N, Wilton S, Dorosz S, Waddy H. 'Sporadic' motoneuron disease due to familial SOD1 mutation with low penetrance [letter]. Lancet 1994; 344: 1773.
82. Swash M, Ingram D. Preclinical and subclinical events in motor neuron disease. J Neurol Neurosurg Psychiatry 1988; 51: 165-8.
83. Tainer JA, Getzoff ED, Beem KM, Richardson JS, Richardson DC. Determination and analysis of the 2 Å structure of copper, zinc Superoxide dismutase. J Mol Biol 1982; 160: 181-217.
84. Takahashi H, Makifuchi T, Nakano R, Sato S, Inuzuka T, Sakimura K, et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn Superoxide dismutase gene. Acta Neuropathol (Berl) 1994; 88: 185-8.
85. Tsuda T, Munthasser S, Fraser PE, Percy ME, Rainero I, Vaula G, et al. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 1994; 13: 727-36.
86. Watanabe M, Aoki M, Abe K, Shoji M, Iizuka T, Ikeda Y, et al. A novel missense point mutation (S134N) of the Cu/Zn Superoxide dismutase gene in a patient with familial motor neuron disease. Hum Mutat 1997; 9: 69-71.
87. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105-16.
88. Yulug IG, Katsanis N, de Belleroche J, Collinge J, Fisher EMC. An improved protocol for the analysis of SOD1 gene mutations, and a new mutation in exon 4 [published erratum appears in Hum Mol Genet 1995; 4: 1474]. Hum Mol Genet 1995; 4: 1101-4.